211 
Phylogica, an Australian peptide drug discovery company, announced today that NAOS Asset Management has increased its shareholding to 51,492,121 shares (representing 11.5% of Phylogica’s issued share capital). This is an increase of 10,155,739 shares from NAOS’s previous reported holding in … Read all
NAOS held by Citicorp Nominees increases Phylogica holdings to 11.5%
|
CathRx Announces Strategic and Management Changes
Under the revised strategy, CathRx Ltd (ASX: CXD) plans to become a catheter technology design house focused on the improvement of its product platform and the addition of new innovative designs.CathRx advises that despite extensive negotiations it has not yet been able to conclude a suitable licence and co-oper… Read all
|
Viralytics Patients commence injections in U.S. Phase II melanoma trial
Viralytics (ASX: VLA) provided an update of its lead product, CAVATAK in the 3 clinical trials the Company is currently running. 1) Phase II CALM study: U.S. based 54 patient intratumoural late stage melanoma trial. This is the first CAVATAK trial to be revie… Read all
|
LifeScan Launch OneTouch® Verio System in the United States
Universal Biosensors, Inc. (ASX: UBI) today announced that LifeScan, Inc. has launched the OneTouch® VerioTM IQ system in the United States. The launch represents a major milestone in the global roll-out of the OneTouch® Verio TM technology. The OneTouch Verio system is now available in all major self monitoring blood glucose (SMBG) markets&n… Read all
|
Phylogica does a new tier 1 Pharama deal
Phylogica Ltd (ASX: PYC, XETRA: PH7) reported that it has has signed its fourth partnership with a major pharmaceutical company. Today, we have announced a Collaboration and Option agreement with Janssen Biotech, Inc., which is one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Thi… Read all
|
China says man dies of bird flu - without contact to live poultry
(Reuters) - A man in southern China's Guangdong province died of bird flu Saturday a week after being admitted to hospital with a fever, state media reported. The 39-year-old bus driver living in Shenzhen, just across the border from Hong Kong, developed symptoms on December 21 and was admitted to a hospital on December 25 because of severe pneumonia, the official Xinhua news agency said… Read all
|
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use